153 related articles for article (PubMed ID: 23621424)
1. Validity of the diagnosis of pre-eclampsia in the Medical Birth Registry of Norway.
Thomsen LC; Klungsøyr K; Roten LT; Tappert C; Araya E; Baerheim G; Tollaksen K; Fenstad MH; Macsali F; Austgulen R; Bjørge L
Acta Obstet Gynecol Scand; 2013 Aug; 92(8):943-50. PubMed ID: 23621424
[TBL] [Abstract][Full Text] [Related]
2. Validity of pre-eclampsia registration in the medical birth registry of norway for women participating in the norwegian mother and child cohort study, 1999-2010.
Klungsøyr K; Harmon QE; Skard LB; Simonsen I; Austvoll ET; Alsaker ER; Starling A; Trogstad L; Magnus P; Engel SM
Paediatr Perinat Epidemiol; 2014 Sep; 28(5):362-71. PubMed ID: 25040774
[TBL] [Abstract][Full Text] [Related]
3. Validity of a selection of pregnancy complications in the Medical Birth Registry of Norway.
Moth FN; Sebastian TR; Horn J; Rich-Edwards J; Romundstad PR; Åsvold BO
Acta Obstet Gynecol Scand; 2016 May; 95(5):519-27. PubMed ID: 26867143
[TBL] [Abstract][Full Text] [Related]
4. Validation study of uterine rupture registration in the Medical Birth Registry of Norway.
Al-Zirqi I; Stray-Pedersen B; Forsén L; Daltveit AK; Vangen S;
Acta Obstet Gynecol Scand; 2013 Sep; 92(9):1086-93. PubMed ID: 23590688
[TBL] [Abstract][Full Text] [Related]
5. Validation of disease registration in pregnant women in the Medical Birth Registry of Norway.
Engeland A; Bjørge T; Daltveit AK; Vollset SE; Furu K
Acta Obstet Gynecol Scand; 2009; 88(10):1083-9. PubMed ID: 19657758
[TBL] [Abstract][Full Text] [Related]
6. Hypertensive disorders in pregnancy and fetal death at different gestational lengths: a population study of 2 121 371 pregnancies.
Ahmad AS; Samuelsen SO
BJOG; 2012 Nov; 119(12):1521-8. PubMed ID: 22925135
[TBL] [Abstract][Full Text] [Related]
7. Registration of Down syndrome in the Medical Birth Registry of Norway: validity and time trends.
Melve KK; Lie RT; Skjaerven R; Van Der Hagen CB; Gradek GA; Jonsrud C; Braathen GJ; Irgens LM
Acta Obstet Gynecol Scand; 2008; 87(8):824-30. PubMed ID: 18607831
[TBL] [Abstract][Full Text] [Related]
8. Degree of fetal growth restriction associated with schizophrenia risk in a national cohort.
Eide MG; Moster D; Irgens LM; Reichborn-Kjennerud T; Stoltenberg C; Skjærven R; Susser E; Abel K
Psychol Med; 2013 Oct; 43(10):2057-66. PubMed ID: 23298736
[TBL] [Abstract][Full Text] [Related]
9. Can we predict recurrence of pre-eclampsia or gestational hypertension?
Brown MA; Mackenzie C; Dunsmuir W; Roberts L; Ikin K; Matthews J; Mangos G; Davis G
BJOG; 2007 Aug; 114(8):984-93. PubMed ID: 17573736
[TBL] [Abstract][Full Text] [Related]
10. Pre-eclampsia in pregnancy and subsequent risk for breast cancer.
Vatten LJ; Romundstad PR; Trichopoulos D; Skjaerven R
Br J Cancer; 2002 Oct; 87(9):971-3. PubMed ID: 12434286
[TBL] [Abstract][Full Text] [Related]
11. Recurrence of pre-eclampsia across generations: exploring fetal and maternal genetic components in a population based cohort.
Skjaerven R; Vatten LJ; Wilcox AJ; Rønning T; Irgens LM; Lie RT
BMJ; 2005 Oct; 331(7521):877. PubMed ID: 16169871
[TBL] [Abstract][Full Text] [Related]
12. Adverse perinatal outcome and later kidney biopsy in the mother.
Vikse BE; Irgens LM; Bostad L; Iversen BM
J Am Soc Nephrol; 2006 Mar; 17(3):837-45. PubMed ID: 16421228
[TBL] [Abstract][Full Text] [Related]
13. Complications during pregnancy in women with epilepsy: population-based cohort study.
Borthen I; Eide MG; Veiby G; Daltveit AK; Gilhus NE
BJOG; 2009 Dec; 116(13):1736-42. PubMed ID: 19781049
[TBL] [Abstract][Full Text] [Related]
14. Cytomegalovirus antibody status at 17-18 weeks of gestation and pre-eclampsia: a case-control study of pregnant women in Norway.
Strand KM; Odland ML; Iversen AC; Nordbø SA; Vik T; Austgulen R
BJOG; 2012 Oct; 119(11):1316-23. PubMed ID: 22804776
[TBL] [Abstract][Full Text] [Related]
15. The effect of recurrent miscarriage and infertility on the risk of pre-eclampsia.
Trogstad L; Magnus P; Moffett A; Stoltenberg C
BJOG; 2009 Jan; 116(1):108-13. PubMed ID: 19087081
[TBL] [Abstract][Full Text] [Related]
16. A validation of the diagnosis of obstetric sphincter tears in two Norwegian databases, the Medical Birth Registry and the Patient Administration System.
Baghestan E; Børdahl PE; Rasmussen SA; Sande AK; Lyslo I; Solvang I
Acta Obstet Gynecol Scand; 2007; 86(2):205-9. PubMed ID: 17364284
[TBL] [Abstract][Full Text] [Related]
17. Role of proteinuria in defining pre-eclampsia: clinical outcomes for women and babies.
Thornton CE; Makris A; Ogle RF; Tooher JM; Hennessy A
Clin Exp Pharmacol Physiol; 2010 Apr; 37(4):466-70. PubMed ID: 19930427
[TBL] [Abstract][Full Text] [Related]
18. The prevalence of pre-eclampsia and obstetric outcome in pregnancies of normotensive and hypertensive women attending a hospital specialist clinic.
Lydakis C; Beevers M; Beevers DG; Lip GY
Int J Clin Pract; 2001; 55(6):361-7. PubMed ID: 11501223
[TBL] [Abstract][Full Text] [Related]
19. Secular trends in the epidemiology of pre-eclampsia throughout 40 years in Norway: prevalence, risk factors and perinatal survival.
Klungsøyr K; Morken NH; Irgens L; Vollset SE; Skjaerven R
Paediatr Perinat Epidemiol; 2012 May; 26(3):190-8. PubMed ID: 22471678
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular mortality after pre-eclampsia in one child mothers: prospective, population based cohort study.
Skjaerven R; Wilcox AJ; Klungsøyr K; Irgens LM; Vikse BE; Vatten LJ; Lie RT
BMJ; 2012 Nov; 345():e7677. PubMed ID: 23186909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
